Literature DB >> 26330398

Giant axonal neuropathy-like disease in an Alexandrine parrot (Psittacula eupatria).

Andrew Stent1, Matthew Gosbell2, Liliana Tatarczuch2, Brian A Summers2.   

Abstract

A chronic progressive neurological condition in an Alexandrine parrot (Psittacula eupatria) was manifest as intention tremors, incoordination, and seizure activity. Histology revealed large eosinophilic bodies throughout the central nervous system, and electron microscopy demonstrated that these bodies were greatly expanded axons distended by short filamentous structures that aggregated to form long strands. The presence of periodic acid-Schiff-positive material within the neuronal bodies of Purkinje cells and ganglionic neurons is another distinctive feature of this disease. The histological features of this case display some features consistent with giant axonal neuropathy as reported in humans and dogs. Based on investigation of the lineage in this case, an underlying inherited defect is suspected, but some additional factor appears to have altered the specific disease presentation in this bird.
© 2015 The Author(s).

Entities:  

Keywords:  Avian; degenerative; giant axonal neuropathy; histology; nervous

Mesh:

Year:  2015        PMID: 26330398     DOI: 10.1177/1040638715603423

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  2 in total

1.  Lafora Disease and Alpha-Synucleinopathy in Two Adult Free-Ranging Moose (Alces alces) Presenting with Signs of Blindness and Circling.

Authors:  Madhu Ravi; Atilano Lacson; Margo Pybus; Mark C Ball
Journal:  Animals (Basel)       Date:  2022-06-25       Impact factor: 3.231

2.  Evaluation of Bleb Morphology and Reduction in IOP and Glaucoma Medication following Implantation of a Novel Gel Stent.

Authors:  Antonio Maria Fea; Roberta Spinetta; Paola Maria Loredana Cannizzo; Giulia Consolandi; Carlo Lavia; Vittoria Aragno; Francesco Germinetti; Teresa Rolle
Journal:  J Ophthalmol       Date:  2017-06-20       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.